L-citrulline/Finding
One finding, on its own
A single claim from the graph, with the evidence strength computed from its study, the sentence it was drawn from, and the paper. This address does not change.
Decreases repeated-sprint performance decrement
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Finding“RSP was improved (i.e., evidenced by a decrease Sdec) in CM compared to PLA (Sdec: CM, 4.68 ± 1.82% vs. PLA, 6.10 ± 1.83%; p = 0.034; ES = 0.77) (Figure.”
Quoted verbatim from Effects of 3 days of citrulline malate supplementation on short-duration repeated sprint running performance in male team sport athletes.. - Study
- crossover
- Participants
- 13
- Duration
- 3 days
- Dose
- Citrulline malate (CM1000, ROS Nutrition), eight 1000 mg tablets daily (8 g/day), taken with breakfast on the two days before and on the morning of each trial.
- Population
- Thirteen male university-level team sport athletes drawn from rugby union, soccer, Gaelic games and field hockey squads, aged 18-30 years and tested during their competitive season.
Effects of 3 days of citrulline malate supplementation on short-duration repeated sprint running performance in male team sport athletes.2024PMID:38874989Permalink
Keep reading
- Everything the graph holds on L-citrulline
- Every compound studied against Repeated-sprint performance decrement
- How to read the evidence strength and the marks
To cite this finding: https://catalystproject.ai/e/01M12SE306JAHZTBY1YWHTK13X